Skip to main content
OpenTrials

Clinical trial condition

Gastrointestinal Diseases

Explore clinical trials studying Gastrointestinal Diseases. Study availability and eligibility vary by location and protocol.

18,009 public trials 3,508 recruiting studies
Refine in advanced search Browse all conditions

Gastrointestinal Diseases trial results

Terminated

Study of Evorpacept (ALX148) With Cetuximab and Pembrolizumab for Refractory Microsatellite Stable Metastatic Colorectal Cancer

NCT05167409

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Rutgers Cancer insititute New Brunswick, New Jersey, United States
  • Inova Schar Cancer Institute Fairfax, Virginia, United States
View Trial Details
Terminated

A Study of Nivolumab-relatlimab Fixed-dose Combination Versus Regorafenib or TAS-102 in Participants With Later-lines of Metastatic Colorectal Cancer

NCT05328908

Conditions
Brain Diseases, Central Nervous System Diseases, Cerebellar Diseases, +18 more
Locations
  • Local Institution - 0044 Springdale, Arkansas, United States
  • Local Institution - 0012 Los Angeles, California, United States
  • Local Institution - 0117 Norwich, Connecticut, United States
  • Local Institution - 0025 Miami, Florida, United States
View all 139 locations
View Trial Details
Terminated

Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Plus Chemotherapy in Participants With Metastatic Esophageal Carcinoma (MK-7902-014/E7080-G000-320/LEAP-014).

NCT04949256

Conditions
Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +14 more
Locations
  • City of Hope ( Site 0102) Duarte, California, United States
  • MedStar Washington Hospital Center ( Site 0186) Washington D.C., District of Columbia, United States
  • James Graham Brown Cancer Center ( Site 0117) Louisville, Kentucky, United States
  • Norton Cancer Institute ( Site 0116) Louisville, Kentucky, United States
View all 198 locations
View Trial Details

Related conditions